ATE191502T1 - Corticotropinauslösefaktor-bindendes protein - Google Patents

Corticotropinauslösefaktor-bindendes protein

Info

Publication number
ATE191502T1
ATE191502T1 AT92904821T AT92904821T ATE191502T1 AT E191502 T1 ATE191502 T1 AT E191502T1 AT 92904821 T AT92904821 T AT 92904821T AT 92904821 T AT92904821 T AT 92904821T AT E191502 T1 ATE191502 T1 AT E191502T1
Authority
AT
Austria
Prior art keywords
crf
protein
proteins
residue
useful
Prior art date
Application number
AT92904821T
Other languages
English (en)
Inventor
Ellen Potter
Dominic P Behan
Wolfgang H Fischer
Elizabeth A Linton
Philip J Lowry
Wylie Walker Vale Jr
Original Assignee
Salk Inst For Biological Studi
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi, Univ Reading filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE191502T1 publication Critical patent/ATE191502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92904821T 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein ATE191502T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64134191A 1991-01-15 1991-01-15
PCT/US1992/000331 WO1992013074A1 (en) 1991-01-15 1992-01-13 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp)

Publications (1)

Publication Number Publication Date
ATE191502T1 true ATE191502T1 (de) 2000-04-15

Family

ID=24571955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904821T ATE191502T1 (de) 1991-01-15 1992-01-13 Corticotropinauslösefaktor-bindendes protein

Country Status (6)

Country Link
EP (1) EP0568622B1 (de)
JP (1) JP3090684B2 (de)
AT (1) ATE191502T1 (de)
CA (1) CA2097424A1 (de)
DE (1) DE69230881T2 (de)
WO (1) WO1992013074A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464757A (en) * 1991-01-15 1995-11-07 The Salk Institute For Biological Studies DNA encoding CRF binding protein
US5587462A (en) * 1993-11-08 1996-12-24 The Salk Institute For Biological Studies Brain-derived membrane-associated CRF binding proteins
AU704838B2 (en) * 1994-09-12 1999-05-06 Trustees Of The University Of Pennsylvania, The Corticotropin release inhibiting factor and methods of using same
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
EP0866856A1 (de) * 1995-11-14 1998-09-30 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Crf analoge und deren verwendung in photoaffinitätsmarkierung von crf-rezeptoren
JP5957443B2 (ja) * 2011-03-28 2016-07-27 長瀬産業株式会社 フェリチンの製造方法
WO2018132768A1 (en) * 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity
US11173992B2 (en) 2017-12-28 2021-11-16 Legionarus, Llc Buoyancy garment
US11471112B2 (en) 2018-11-21 2022-10-18 Legionarius, Llc Mobile application for wearable device
USD905935S1 (en) 2019-02-20 2020-12-29 Legionarius, Llc Shirt with back pocket
US12478324B2 (en) 2019-02-20 2025-11-25 Legionarius, Llc Sensors for wearable devices

Also Published As

Publication number Publication date
WO1992013074A1 (en) 1992-08-06
CA2097424A1 (en) 1992-07-15
EP0568622A1 (de) 1993-11-10
EP0568622B1 (de) 2000-04-05
DE69230881D1 (de) 2000-05-11
JPH06504445A (ja) 1994-05-26
JP3090684B2 (ja) 2000-09-25
DE69230881T2 (de) 2000-11-16

Similar Documents

Publication Publication Date Title
RU2003131330A (ru) Средства для лечения воспалительных кишечных заболеваний
ATE191502T1 (de) Corticotropinauslösefaktor-bindendes protein
IL212686A0 (en) Oligodendrocyte binding human monoclonal igm antibodies and compositions and uses thereof
ATE165980T1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
DE69835680D1 (de) Therapeutische verwendung von smr1 protein und seinen aktiven derivaten
ATE141288T1 (de) Melaninkonzentrierende hormone und dns die diese expremieren
JP2003534363A (ja) トランスジェニック非ヒト動物由来ヒト血清アルブミン含有化粧組成物
ATE297983T1 (de) Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1
DK0948536T3 (da) G-protein-koblet receptor med et forstörret extracellulært domæne
Tam et al. Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietins
EA200300132A1 (ru) Стресс-белки и пептиды и способы их применения
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
NO962596L (no) Nytt tumorsupressorgen
BRPI0416507A (pt) polipeptìdeo, molécula de ácido nucleico purificada, vetor, célula hospedeira, uso de um polipeptìdeo, uma molécula de ácido nucleico, um vetor, ou uma célula hospedeira, composição farmacêutica, uso de um antagonista de citocina ou um agente anti-inflamatório, uso de polipeptìdeo,uma molécula de ácido nucleico, um vetor, ou uma célula hospedeira,e um antagonista de citocina ou um agente anti-inflamatório, método de tratamento de uma doença em um paciente, e para a identificação de um composto e, animal transgênico não humano
RU98105411A (ru) Способ получения препарата альфа-фетопротеина
DE59208025D1 (de) Neue thrombininhibitorische proteine aus landblutegeln
Pivnik et al. Alteration of intraerythrocyte proteolytic degradation of hemoglobin during Hodgkin's disease
DE69712182D1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
Bocci What are the roles of interferons in physiological conditions?
WO2002088378A3 (en) 66784, a novel human potassium channel and uses therefor
JP2671912B2 (ja) 新規抗菌性蛋白、その製造法および用途
Marhaug et al. Characterization of serum amyloid A (SAA) protein in the sheep
RU2110269C1 (ru) Способ стимуляции белково-синтетической функции печени после ее резекции в эксперименте
CN1189480C (zh) 饱食因子及其制备方法
Jahn et al. 65 LIVER MEMBRANE AUTOANTIBODIES (LMA) IN CHRONIC HEPATITIS OF THE AUTOIIMUNE TYPE: CHARACTERIZATION OF THE TARGET ANTIGEN.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties